Receptor involved in brain injury found.Two independent research groups -- one in Japan, the other in Kansas -- have reported isolating two different forms of a specific nerve-cell receptor that may play a role in brain damage caused by stroke, epilepsy or head injury. Both teams claim they have found in rats the receptor for glutamate glutamate /glu·ta·mate/ (gloo´tah-mat) a salt of glutamic acid; in biochemistry, the term is often used interchangeably with glutamic acid. glu·ta·mate n. 1. A salt of glutamic acid. , a neutransmitter involved in nervous system development and memory storage. Brain cell s appear to release glutamate in increased amounts after injury, and neurologists believe the so-called NMDA receptor (named for its ability to bind to to contract; as, to bind one's self to a wife s>. See also: Bind the lab-made chemical N-methyl-D-aspartate) can kill nerve cells when overstimulated by glutamate. Elias Michaelis of the University of Kansas The University of Kansas (often referred to as KU or just Kansas) is an institution of higher learning in Lawrence, Kansas. The main campus resides atop Mount Oread. in Lawrence says the NMDA receptor purified by his group can bind to both glutamate and NMDA NMDA N-methyl-D-asparate . He and his colleagues found that they could block the binding of both chemicals by first adding antibodies that stick to the receptor. Further, they found that adding fibroblast growth factor Fibroblast growth factors, or FGFs, are a family of growth factors involved in wound healing and embryonic development. The FGFs are heparin-binding proteins and interactions with cell-surface associated heparan sulfate proteoglycans have been shown to be essential for FGF -- which also promotes nerve-cell growth --reduced the number ofNMDA receptors on lab-cultured nerve cells, protecting them from death by overexcitation. Michaelis and his colleagues published some of their results in the Nov. 7 NATURE. In the same issue, Shigetada Nakanishi and co-workers at Kyoto University reported purifying a candidate NMDA receptor with a very different structure. Michaelis contends that both groups have uncovered NMDA receptors, but of different types. Neuroscientist Charles F. Stevens remains skeptical. Stevens, of the Salk Institute for Biological Studies The Salk Institute for Biological Studies is an independent, non-profit, scientific research laboratory located in La Jolla, California. It was founded in 1960 by Jonas Salk, M.D., the developer of the polio vaccine. in La Jolla, Calif., says he believes Nakanishi's team has found all or part of the real NMDA receptor, but he questions the Kansas researchers' finding because their candidate receptor bears no structural similarity to previously described receptors for other molecules. |
|
||||||||||||||||||||

Printer friendly
Cite/link
Email
Feedback
Reader Opinion